URAC Disease Management Accreditation Consulting — Integral Healthcare Solutions

Last updated: April 2026

IHS is a specialized healthcare accreditation consulting firm with over 25 years of URAC expertise. We guide health plans, disease management organizations, population health vendors, and managed care entities through every phase of URAC Disease Management Accreditation — from initial gap analysis and policy development through mock survey, AccreditNet submission, and validation review.

What Is URAC Disease Management Accreditation?

URAC Disease Management Accreditation is a structured quality credential from the Utilization Review Accreditation Commission recognizing organizations that meet evidence-based standards for managing defined populations living with chronic conditions and co-morbidities. The program aligns with national efforts to prevent and control chronic diseases by improving individual health status — validating that an organization has built an effective, multi-format patient communication and education model alongside the quality management infrastructure to sustain it.

Seventy-five percent of Americans live with at least one chronic condition. Fifty percent carry multiple conditions. Disease management at scale requires more than clinical protocols — it requires documented risk stratification, population identification, individualized engagement strategies, evidence-based practice integration, provider collaboration, and ongoing quality monitoring. URAC Disease Management Accreditation provides an independent third-party validation that all of these elements are present and functioning.

The credential is not a certification of any single disease state. It covers an organization's overarching model for managing chronic illness across its member or patient population — and it signals to health plan clients, employer customers, government program administrators, and providers that the organization's disease management approach meets the industry's most rigorous standard.

Who Needs URAC Disease Management Accreditation?

URAC Disease Management Accreditation is designed for any organization managing a defined population with chronic disease or co-morbid conditions. Eligible organizations include:

• Health plans and managed care organizations — HMOs, PPOs, and integrated health systems running in-house disease management programs for their covered populations
• Disease management companies — standalone DM vendors contracting with health plans, employer groups, or government programs to manage specific chronic populations
• Population health management organizations — entities managing complex, multi-condition populations for value-based care contracts, ACOs, or state Medicaid programs
• Employer-sponsored health program administrators — organizations running disease management programs for self-insured employer groups seeking quality validation
• Integrated delivery networks and health systems — systems with defined DM programs across their patient population that benefit from external quality validation

The driving motivations vary: contract requirements from commercial health plan clients, state Medicaid managed care procurement preferences, competitive differentiation in a crowded DM vendor market, or internal quality discipline. Whatever the motivation, the accreditation process is substantively the same — and the preparation requirements are equally demanding.

The Market Context: Why Disease Management Accreditation Matters Now

URAC remains the primary accrediting body actively maintaining Disease Management Accreditation standards. NCQA, once a comparable option, retired its Disease Management Accreditation and Certification programs in 2019, transitioning to broader Population Health Program Accreditation. This consolidation makes URAC Disease Management Accreditation the most recognized third-party DM quality credential in the market.

At the same time, the burden of chronic disease has accelerated. Chronic conditions — diabetes, heart disease, COPD, asthma, chronic kidney disease, behavioral health conditions, and their combinations — account for the majority of preventable healthcare spending in the United States. Health plan clients, employer groups, and government programs are under increasing pressure to demonstrate that their disease management investments are producing measurable outcomes: reductions in emergency utilization, improved medication adherence, lower hospitalization rates, and better quality-of-life metrics.

URAC Disease Management Accreditation provides that demonstration. It moves a DM organization's quality claims from marketing language to independently validated evidence — a material distinction in competitive procurement environments.

What URAC Disease Management Standards Cover

URAC Disease Management standards are organized around four core functional areas. The standards are evidence-based, regularly updated, and designed to assess demonstrated operational practice — not just policy documentation.

• Patient communication and education — Standards require multi-format, health-literacy-appropriate communication strategies that are individualized to the patient population and specific conditions managed. Generic one-size-fits-all communications do not satisfy these standards.
• Risk management oversight — Organizations must demonstrate structured risk management review protocols, including identification of high-risk individuals within the managed population, escalation pathways, and documented response to identified risks.
• Quality management infrastructure — A functioning quality management system is required: documented QI program structure, defined performance metrics, outcome tracking, and evidence of continuous improvement activity — with a look-back period demonstrating this infrastructure was operational before the survey.
• Consumer engagement strategies — Standards address how the organization actively engages members or patients in their own disease management — shared decision-making, self-management support, behavioral change strategies, and measurement of engagement effectiveness.

Provider collaboration is woven throughout: standards address how the DM organization interfaces with treating clinicians, communicates care plan information, and avoids duplication or conflict with primary care management.

How IHS Approaches URAC Disease Management Accreditation

IHS brings over 25 years of URAC expertise to Disease Management Accreditation engagements, led by Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC. That institutional knowledge is not replicated by general healthcare consultants. We know how URAC standards are written, how they are interpreted in review, and where organizations consistently fail.

Our engagement model follows a structured six-phase approach:

1. Gap Analysis and Readiness Assessment — We conduct a Standard-by-Standard Review against current URAC Disease Management standards, mapping your existing policies, procedures, quality systems, and operational evidence to each requirement. The output is a prioritized gap register with remediation timelines.
2. Policy and Procedure Development — Where gaps exist, IHS develops compliant policies and procedures in your organization's voice — not generic templates. Every document is reviewed against the specific standard it must satisfy.
3. Quality Management Infrastructure Build — We help establish or strengthen your Quality Management Committee structure, performance measurement framework, outcome tracking systems, and continuous improvement documentation to meet both the structural and look-back period requirements.
4. Look-Back Period Strategy — URAC reviewers assess operational history, not just current-state documentation. IHS builds a realistic look-back period strategy from day one so that by the time your application is submitted, the required operational evidence exists.
5. Mock Survey — Before AccreditNet submission, IHS conducts a mock survey replicating the URAC validation review process — interviewing staff, reviewing documentation, and identifying any remaining gaps. Organizations that complete a rigorous mock survey significantly outperform those that do not.
6. AccreditNet Submission, RFI Response, and Validation Review Preparation — IHS supports the complete AccreditNet submission process, drafts RFI responses if URAC requests additional information following desktop review, and prepares staff for validation review interviews.

Why IHS for URAC Disease Management Accreditation

• Unmatched URAC institutional knowledge. Thomas G. Goddard, JD, PhD served as former Chief Operating Officer and General Counsel of URAC before founding IHS. No other consulting firm has that vantage point on how URAC standards are developed, interpreted, and applied.
• Specialized, not generalist. IHS focuses on accreditation and compliance. We do not dilute that focus with unrelated consulting lines. Every engagement benefits from accumulated cross-client intelligence on what works and what fails in URAC review.
• Standard-by-Standard precision. We evaluate your organization against the specific standards, not general best practices. The difference matters — URAC reviewers score against standard text, and organizations that prepare against the actual language consistently outperform those that prepare conceptually.
• Realistic timelines and expectations. We will not promise a six-month path when your organization's readiness requires twelve. Honest readiness assessment at the outset prevents the failed surveys and resubmission cycles that result from underestimating preparation requirements.
• Principal-led engagement. IHS engagements are led by senior principals — not staffed with junior associates after the initial sales call. The expertise you evaluate is the expertise you receive.

Related URAC Accreditation Programs

Disease management rarely exists in isolation. Organizations managing chronic populations often carry or should consider adjacent URAC credentials:

• URAC Health Utilization Management Accreditation — for organizations conducting prior authorization or clinical review of services for their DM population
• URAC Case Management Accreditation — for organizations providing individual case management alongside population-level DM programs
• URAC Health Plan Accreditation — for health plans seeking comprehensive quality validation across all functional areas
• URAC Medicare Advantage Organization Accreditation — for MA plans with disease management program components
• NCQA Population Health Program Accreditation — NCQA's successor to its retired DM program, relevant for organizations pursuing NCQA recognition rather than or in addition to URAC

IHS can advise on the optimal accreditation strategy for your organization's operational scope and market requirements — including whether a single credential or coordinated multi-body approach best serves your situation.

Ready to Pursue URAC Disease Management Accreditation?

The path to URAC Disease Management Accreditation begins with an honest assessment of where your organization stands against current standards. IHS provides that assessment — and the full consulting support to close every gap between your current state and accreditation.

Schedule a Free Discovery Session to discuss your organization's disease management program, accreditation timeline, and where IHS can add the most value.